Fluticasone Propionate/Formoterol fumarate/Glycopyrrolate

N/A

Report date: 2025/11/14 13:58:48

Base Information

Drug NameFluticasone Propionate/Formoterol fumarate/Glycopyrrolate
Drug Alias NameFluticasone propionate/glycopyrrolate/formoterol fumarateGlycopyrrolate/formoterol fumarate/fluticasone propionateFluticasone propionate/formoterol fumarate/glycopyrrolate - Glenmark Pharmaceuticals
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor agonistsMuscarinic acetylcholine receptor antagonists +[4] 
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptorGlucocorticoid receptor +[4] 
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsYes Formoterol FumarateFluticasone PropionateGlycopyrrolate Tosylate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEurofarma Laboratorios SaGlenmark Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A